Your browser doesn't support javascript.
loading
The HDAC3-SMARCA4-miR-27a axis promotes expression of the PAX3:FOXO1 fusion oncogene in rhabdomyosarcoma.
Bharathy, Narendra; Berlow, Noah E; Wang, Eric; Abraham, Jinu; Settelmeyer, Teagan P; Hooper, Jody E; Svalina, Matthew N; Ishikawa, Yoshihiro; Zientek, Keith; Bajwa, Zia; Goros, Martin W; Hernandez, Brian S; Wolff, Johannes E; Rudek, Michelle A; Xu, Linping; Anders, Nicole M; Pal, Ranadip; Harrold, Alexandria P; Davies, Angela M; Ashok, Arya; Bushby, Darnell; Mancini, Maria; Noakes, Christopher; Goodwin, Neal C; Ordentlich, Peter; Keck, James; Hawkins, Douglas S; Rudzinski, Erin R; Chatterjee, Bishwanath; Bächinger, Hans Peter; Barr, Frederic G; Liddle, Jennifer; Garcia, Benjamin A; Mansoor, Atiya; Perkins, Theodore J; Vakoc, Christopher R; Michalek, Joel E; Keller, Charles.
Afiliação
  • Bharathy N; Children's Cancer Therapy Development Institute, Beaverton, OR 97005, USA.
  • Berlow NE; Children's Cancer Therapy Development Institute, Beaverton, OR 97005, USA.
  • Wang E; Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA.
  • Abraham J; Department of Pediatrics, Oregon Health & Science University, Portland, OR 97239, USA.
  • Settelmeyer TP; Children's Cancer Therapy Development Institute, Beaverton, OR 97005, USA.
  • Hooper JE; Department of Pathology, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA.
  • Svalina MN; Children's Cancer Therapy Development Institute, Beaverton, OR 97005, USA.
  • Ishikawa Y; Research Center, Shriners Hospital for Children, Portland, OR 97239, USA.
  • Zientek K; Research Center, Shriners Hospital for Children, Portland, OR 97239, USA.
  • Bajwa Z; Children's Cancer Therapy Development Institute, Beaverton, OR 97005, USA.
  • Goros MW; Department of Pathology, Oregon Health & Science University, Portland, OR 97239, USA.
  • Hernandez BS; Department of Epidemiology and Biostatistics, University of Texas Health Science Center, San Antonio, TX 78229, USA.
  • Wolff JE; Department of Epidemiology and Biostatistics, University of Texas Health Science Center, San Antonio, TX 78229, USA.
  • Rudek MA; Department of Pediatric Hematology Oncology and Blood and Marrow Transplantation, Cleveland Clinic Children's, Cleveland, OH 44195, USA.
  • Xu L; Department of Oncology, School of Medicine, Johns Hopkins University, Baltimore, MD 21231, USA.
  • Anders NM; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21224, USA.
  • Pal R; Division of Clinical Pharmacology, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD 21231, USA.
  • Harrold AP; Department of Oncology, School of Medicine, Johns Hopkins University, Baltimore, MD 21231, USA.
  • Davies AM; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21224, USA.
  • Ashok A; Department of Oncology, School of Medicine, Johns Hopkins University, Baltimore, MD 21231, USA.
  • Bushby D; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21224, USA.
  • Mancini M; Electrical and Computer Engineering, Texas Tech University, Lubbock, TX 79409, USA.
  • Noakes C; Children's Cancer Therapy Development Institute, Beaverton, OR 97005, USA.
  • Goodwin NC; Champions Oncology, Rockville, MD 20850, USA.
  • Ordentlich P; Champions Oncology, Rockville, MD 20850, USA.
  • Keck J; Champions Oncology, Rockville, MD 20850, USA.
  • Hawkins DS; Champions Oncology, Rockville, MD 20850, USA.
  • Rudzinski ER; Champions Oncology, Rockville, MD 20850, USA.
  • Chatterjee B; Champions Oncology, Rockville, MD 20850, USA.
  • Bächinger HP; Syndax Pharmaceuticals, Waltham, MA 02451, USA.
  • Barr FG; The Jackson Laboratory, Sacramento, CA 95838, USA.
  • Liddle J; Seattle Children's Hospital, Seattle, WA 98105, USA.
  • Garcia BA; Seattle Children's Hospital, Seattle, WA 98105, USA.
  • Mansoor A; Cancer Molecular Pathology Section, Laboratory of Pathology, National Cancer Institute, Bethesda, MD 20892-1500, USA.
  • Perkins TJ; Research Center, Shriners Hospital for Children, Portland, OR 97239, USA.
  • Vakoc CR; Department of Biochemistry and Molecular Biology, Oregon Health & Science University, Portland, OR 97239, USA.
  • Michalek JE; Cancer Molecular Pathology Section, Laboratory of Pathology, National Cancer Institute, Bethesda, MD 20892-1500, USA.
  • Keller C; Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, PA 19104, USA.
Sci Signal ; 11(557)2018 11 20.
Article em En | MEDLINE | ID: mdl-30459282
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Proteínas Nucleares / Proteínas de Fusão Oncogênica / Rabdomiossarcoma Alveolar / DNA Helicases / MicroRNAs / Fatores de Transcrição Box Pareados / Inibidores de Histona Desacetilases / Histona Desacetilases Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Sci Signal Assunto da revista: CIENCIA / FISIOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Proteínas Nucleares / Proteínas de Fusão Oncogênica / Rabdomiossarcoma Alveolar / DNA Helicases / MicroRNAs / Fatores de Transcrição Box Pareados / Inibidores de Histona Desacetilases / Histona Desacetilases Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Sci Signal Assunto da revista: CIENCIA / FISIOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos